 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Co-Diagnostics, Inc. engages in the development and innovation of molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications. Its diagnostics systems enable very rapid, low-cost, molecular testing for organisms and genetic diseases by automating historically complex procedures in both the development and administration of tests. The company was founded by Brent C. Satterfield and Dwight Howard Egan on April 18, 2013 and is headquartered in Salt Lake City, UT.

Current Price	$1.09
Prev Close	$1.07
Open	$1.08
Dividend Yield	0.00%
50-Day Moving Average	$1.36
Beta	0.76
Avg. Volume	98,080.00
PE Ratio	-1.04

52-Week High	$7.13
52-Week Low	$0.975
Market Capitalization	$32.38M
EPS	-$1.03
Price to Book	0.30
Revenue Per Employee	$83,593.95
Enterprise Value/EBITDA	1.02

CODX Co-Diagnostics Inc

About

Feed

Fundamentals

News